Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

• Fabiola Martel,
• Juliana Cuervo-Rojas,
• Juana Ángel,
• Beatriz Ariza,
• John Mario González,
• Carolina Ramírez-Santana,
• Yeny Acosta-Ampudia,
• Luisa Murcia-Soriano,
• Norma Montoya,
• Claudia Cecilia Cardozo-Romero,
• Sandra Liliana Valderrama-Beltrán,
• Magda Cepeda,
• Julio César Castellanos,
• Carlos Gómez-Restrepo,
• Federico Perdomo-Celis,
• Andreu Gazquez,
• Alexandria Dickson,
• James D. Brien,
• José Mateus,
• Alba Grifoni,
• Alessandro Sette,
• Alessandro Sette,
• Daniela Weiskopf,
• Manuel A. Franco

Affiliations

Fabiola Martel

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Juliana Cuervo-Rojas

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Juana Ángel

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Beatriz Ariza

Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia

John Mario González

Group of Basic Medical Sciences, School of Medicine, Universidad de Los Andes, Bogotá, Colombia

Carolina Ramírez-Santana

Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia

Yeny Acosta-Ampudia

Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia

Luisa Murcia-Soriano

Hospital Universitario Mayor-Méderi, Universidad El Rosario, Bogotá, Colombia

Norma Montoya

Head Clinical Laboratory Unit, Clínica del Occidente, Bogotá, Colombia

Claudia Cecilia Cardozo-Romero

Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia

Sandra Liliana Valderrama-Beltrán

Division of Infectious Diseases, Department of Internal Medicine. School of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio Infectious Diseases Research Group, Bogotá, Colombia

Magda Cepeda

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Julio César Castellanos

General Direction, Hospital Universitario San Ignacio, Bogotá, Colombia

Carlos Gómez-Restrepo

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Federico Perdomo-Celis

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Andreu Gazquez

0Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States

Alexandria Dickson

0Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States

James D. Brien

0Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States

José Mateus

1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States

Alba Grifoni

1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States

Alessandro Sette

1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States

Alessandro Sette

2Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States

Daniela Weiskopf

1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States

Manuel A. Franco

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia